Innovent Biologics Balance Sheet Health
Financial Health criteria checks 4/6
Innovent Biologics has a total shareholder equity of CN¥12.5B and total debt of CN¥3.5B, which brings its debt-to-equity ratio to 28.1%. Its total assets and total liabilities are CN¥20.6B and CN¥8.1B respectively.
Key information
28.1%
Debt to equity ratio
CN¥3.52b
Debt
Interest coverage ratio | n/a |
Cash | CN¥10.97b |
Equity | CN¥12.53b |
Total liabilities | CN¥8.10b |
Total assets | CN¥20.63b |
Recent financial health updates
No updates
Recent updates
Shareholders May Not Be So Generous With Innovent Biologics, Inc.'s (HKG:1801) CEO Compensation And Here's Why
Jun 14Innovent Biologics, Inc. (HKG:1801) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
May 01There's Reason For Concern Over Innovent Biologics, Inc.'s (HKG:1801) Massive 27% Price Jump
Feb 28Are Investors Undervaluing Innovent Biologics, Inc. (HKG:1801) By 33%?
Jan 12Innovent Biologics, Inc.'s (HKG:1801) Price Is Out Of Tune With Revenues
Dec 25An Intrinsic Calculation For Innovent Biologics, Inc. (HKG:1801) Suggests It's 34% Undervalued
Sep 11Is There An Opportunity With Innovent Biologics, Inc.'s (HKG:1801) 50% Undervaluation?
Jun 04Benign Growth For Innovent Biologics, Inc. (HKG:1801) Underpins Its Share Price
May 14Innovent Biologics, Inc. (HKG:1801) Shares Could Be 50% Below Their Intrinsic Value Estimate
Dec 27Financial Position Analysis
Short Term Liabilities: 1801's short term assets (CN¥13.4B) exceed its short term liabilities (CN¥4.5B).
Long Term Liabilities: 1801's short term assets (CN¥13.4B) exceed its long term liabilities (CN¥3.6B).
Debt to Equity History and Analysis
Debt Level: 1801 has more cash than its total debt.
Reducing Debt: 1801's debt to equity ratio has increased from 18.9% to 28.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1801 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 1801 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.